Hypoxia assessed by 18F-fluoromisonidazole positron emission tomography in newly diagnosed gliomas

Nuclear Medicine Communications

Volumn 33, Issue 6, 2012, Pages 621-625

  Yamamoto, Yuka ^b   Maeda, Yukito ^a   Kawai, Nobuyuki ^b   Kudomi, Nobuyuki ^c   Aga, Fumitoshi ^b   Ono, Yuko ^b   Nishiyama, Yoshihiro ^b  

^a KAGAWA UNIVERSITY HOSPITAL   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

^c KAGAWA UNIVERSITY   (Japan)

Author keywords

18F fluoromisonidazole; glioma; positron emission tomography

Indexed keywords

1 FLUORO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL F 18; 1 FLUORO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL; DIAGNOSTIC AGENT; DRUG DERIVATIVE; MISONIDAZOLE; RADIOSENSITIZING AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GRADING; CHILD; CLINICAL ARTICLE; EPENDYMOMA; FEMALE; GLIOBLASTOMA; GLIOMA; HUMAN; HYPOXIA; MALE; NON INVASIVE PROCEDURE; PILOCYTIC ASTROCYTOMA; POSITRON EMISSION TOMOGRAPHY; PRESCHOOL CHILD; SCHOOL CHILD; TUMOR CLASSIFICATION; VENOUS BLOOD; WORLD HEALTH ORGANIZATION; ANOXIA; BRAIN TUMOR; METHODOLOGY; MIDDLE AGED; RETROSPECTIVE STUDY; SCINTISCANNING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANOXIA; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; GLIOMA; HUMANS; MALE; MIDDLE AGED; MISONIDAZOLE; POSITRON-EMISSION TOMOGRAPHY; RADIATION-SENSITIZING AGENTS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84860833963     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e3283529984     Document Type: Article

References (23)

1. Swanson KR, Alvord EC Jr, Murray JD. Virtual brain tumours (gliomas) enhance the reality of medical imaging and highlight inadequacies of current therapy. Br J Cancer 2002; 86:14-18. (Pubitemid 34146334)
2. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007; 114:97-109. (Pubitemid 47103521)
3. 11C]methionine PET, histopathology, and survival in primary brain tumors and recurrence. AJNR Am J Neuroradiol 2006; 27:1432-1437. (Pubitemid 44260122)
4. Kaschten B, Stevenaert A, Sadzot B, Deprez M, Degueldre C, Del Fiore G, et al. Preoperative evaluation of 54 gliomas by PET with fluorine-18- fluorodeoxyglucose and/or carbon-11-methionine. J Nucl Med 1998; 39:778-785. (Pubitemid 28216722)
5. 11C-methionine positron emission tomography and proliferating cell nuclear antigen staining. Neurosurg Rev 1999; 22:210-214. (Pubitemid 30070655)
6. 18F-FDG PET. Eur J Nucl Med Mol Imaging 2005; 32:52-59. (Pubitemid 40142778)
7. Ogawa T, Shishido F, Kanno I, Inugami A, Fujita H, Murakami M, et al. Cerebral gliomas: evaluation with methionine-PET. Radiology 1993; 186:45-53.
8. 18F-fluorothymidine (FLT) PET in patients with newly diagnosed glioma. Eur J Nucl Med Mol Imaging 2008; 35: 2009-2017.
9. 11C]methioninepositron emission tomography as a biological monitoring tool in the treatment of glioma. J Neurosurg 2005; 103:498-507. (Pubitemid 43186642)
10. Brown MJ. The hypoxic cell: a target for selective cancer therapy. Eighteenth Bruce F. Cain Memorial Award Lecture. Cancer Res 1999; 59:5863-5870.
11. Kleihues P, Cavanee WK. Tumours of the nervous system. Pathology and Genetics: World Health Organization Classification of Tumors. Lyon, France: IARC Press; 2000.
12. Hustinx R, Eck SL, Alavi A. Potential applications of PET imaging in developing novel cancer therapies. J Nucl Med 1999; 40:995-1002. (Pubitemid 29269221)
13. 18F-fluoromisonidazole. Int J Radiat Oncol Biol Phys 1992; 22:199-212.
14. 18F]fluoromisonidazole: a pretherapy study of 37 patients. Int J Radiat Oncol Biol Phys 1996; 36:417-428.
15. Valk PE, Mathis CA, Prados MD, Gilbert JC, Budinger TF. Hypoxia in human gliomas: demonstration by PET with fluorine-18-fluoromisonidazole. J Nucl Med 1992; 33:2133-2137.
16. 18F-fluoromisonidazole PET in the assessment of human glioblastomas. J Nucl Med 2009; 50:36-44.
17. 18F-fluoromisonidazole PET in newly diagnosed glioblastoma. Eur J Nucl Med Mol Imaging 2011; 38:441-450.
18. 18F-FDG PET, and immunohistochemical studies. J Nucl Med 2006; 47:410-418. (Pubitemid 46768482)
19. 18F]FDG module. Nucl Med Biol 2005; 32:899-905. (Pubitemid 41505324)
20. Evans SM, Judy KD, Dunphy I, Jenkins WT, Hwang WT, Nelson PT, et al. Hypoxia is important in the biology and aggression of human glial brain tumors. Clin Cancer Res 2004; 10:8177-8184. (Pubitemid 40053376)
21. 18F] fluoromisonidazole (FMISO). Nucl Med Biol 2002; 29:191-197. (Pubitemid 34127952)
22. Tsang RW, Fyles AW, Milosevic M, Syed A, Pintilie M, Levin W, et al. Interrelationship of proliferation and hypoxia in carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2000; 46:95-99. (Pubitemid 30021486)
23. 18F]fluoromisonidazole positron emission tomography before radiotherapy: correlation with time to progression and survival. Clin Cancer Res 2008; 14:2623-2630.